Table 3.
Chi-square associations of variables with immune status among ART-naïve study participants in Addis Ababa, Ethiopia
| Variables | Overall [Number (%)] | CD4 < 200 or stage III/IV [Number (%)] | CD4 < 350 or stage III/IV [Number (%)] | CD4 < 500 or stage III/IV [Number (%)] |
|---|---|---|---|---|
| Gender | ||||
| Male | 171(28.8) | 64(41.6) a | 111(35.5) a | 147(33.7) a |
| Female | 423(71.2) | 90(58.4) | 202(64.5) | 289(66.3) |
| HIV RNA load (copies/mL) | ||||
| < 10,000 | 264(45.2) | 27(17.9) a | 84(27.4) a | 149(34.8) a |
| ≥ 10,000 | 320(54.8) | 124(82.1) | 223(72.6) | 279(65.2) |
| Hemoglobin conc. (g/dL) | ||||
| Non-anemic | 507(88.8) | 117(78.5) a | 252(83.7) a | 362(86.6) b |
| Anemic | 64(11.2) | 32(21.5) | 49(16.3) | 56(13.4) |
| Total cholesterol conc. (mg/dL) | ||||
| > 200 | 95(16.6) | 9(6.2) | 34(11.4) a | 56(13.4) b |
| ≤ 200 | 476(83.4) | 136(93.8) a | 264(88.6) | 362(86.6) |
Note: a, b refer to p value < 0.001 and < 0.01, respectively